(Q35117065)

6 August 2017

1 reference

title

The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease (English)

1 reference

6 August 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

28 December 2023

author name string

Holger Heitsch

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

http://www.tandfonline.com/doi/pdf/10.1517/13543784.12.5.759

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Expert Opinion on Investigational Drugs

28 December 2023

published in

1 reference

6 August 2017

volume

12

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

759-770

1 reference

The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Characterization of bradykinin B2 receptors in adult myocardium and neonatal rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Kinins in pain and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Bradykinin antagonists: new opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Non-peptide antagonists and agonists of the bradykinin B(2) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Bradykinin for the treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Pharmacological characterization of RMP-7, a novel bradykinin agonist in smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

A nonpeptide mimic of bradykinin blunts the development of hypertension in young spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Kinins and cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Interactions among ACE, kinins and NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Antiatherosclerotic effects of ACE inhibitors: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Role of bradykinin in preconditioning and protection of the ischaemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Ischemic preconditioning: from adenosine receptor to KATP channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Activation of mitochondrial ATP-dependent potassium channels by nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Protein kinases and kinase-modulated effectors in the late phase of ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Hypotension in transgenic mice overexpressing human bradykinin B2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Bradykinin B2-receptors mediate the pressor and renal hemodynamic effects of intravenous bradykinin in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Role of endogenous bradykinin in human coronary vasomotor control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Role of kinins in the endothelial protective effect of ischaemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Targeting kinin receptors for the treatment of tissue ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Targeting kinin B(1) receptor for therapeutic neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Dilated and failing cardiomyopathy in bradykinin B(2) receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

In vivo bradykinin B2 receptor activation reduces renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Acute antihypertrophic actions of bradykinin in the rat heart: importance of cyclic GMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Bradykinin improves left ventricular diastolic function under long-term angiotensin-converting enzyme inhibition in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Insulin-induced glucose transporter (GLUT1 and GLUT4) translocation in cardiac muscle tissue is mimicked by bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

Myocardial bradykinin B2-receptor expression at different time points after induction of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.759

21 January 2018

Pharmacological Reviews

1

44

1

BHOOLA KD

1992

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Inhibiting tissue angiotensin-converting enzyme: a pound of flesh without the blood?

28 December 2023

4

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor

28 December 2023

18

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: an in vitro study on human, rabbit and pig vascular B2 receptors

28 December 2023

19

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

FR190997, a novel bradykinin B2 agonist, expresses longer action than bradykinin in paw edema formation and hypotensive response

28 December 2023

20

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

28 December 2023

Pharmacological Reviews

24

47

25

LINZ W

1995

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.

28 December 2023

28

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.

28 December 2023

47

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Effect of bradykinin and its antagonist on survival time after coronary artery occlusion in rats

28 December 2023

50

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Role of bradykinin in protection of ischemic preconditioning in rabbit hearts

28 December 2023

54

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats

28 December 2023

55

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Bradykinin-induced preconditioning in patients undergoing coronary angioplasty

28 December 2023

56

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Bradykinin blocks angiotensin II-induced hypertrophy in the presence of endothelial cells

28 December 2023

63

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Left ventricular hypertrophy and its relation to the cardiac kinin-forming system in hypertensive and diabetic rats

28 December 2023

64

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Bradykinin infusion in chronic cardiac failure and the effects of captopril

28 December 2023

70

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Down-regulation of cardioprotective bradykinin type-2 receptors in the left ventricle of patients with end-stage heart failure

28 December 2023

72

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Insulin sensitivity, clearance and release in kininogen-deficient rats

28 December 2023

77

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

28 December 2023

80

1 reference

https://api.crossref.org/works/10.1517/13543784.12.5.759

28 December 2023

Identifiers

1 reference

6 August 2017

1 reference